Skip to content

CELIDENT

Active Private limited companyfounded 2011active for 15 yearsRue Mitoyenne 14, 7080 FrameriesKBO/BCE: BE 0836.220.271 #2 company by equity in Frameries, Health and social work sector
CELIDENT
Follow ReportCompare

Overview

Lifetime

15 annual accounts with figures on one time axis
peak €113,226 (2017)
€92,663▼ 0.9%
peak €1.8m (2012)
€177,185▲ 69.2%
peak €3.7m (2025)
€3.7m▲ 5.0%
€21,411▼ 38.0%
Board2 names since 2011
1 directorSAPIN Céline Marie Anne
Documentsfilings and deeds
30-06-202631 days before the deadline
2025abbreviated format
Result from €104,714 to €177,185Debts from €34,508 to €21,411Cash from €254,846 to €103,052

Key points

from the 2025 annual accounts

Equity

€3.7m ▲ 5.0%

CELIDENT has made a profit in every financial year since 2011.

Result

€177,185 ▲ 69.2%
€105,0002024€177,0002025

The result rose in 2025 from €104,714 to €177,185.

Turnover

≈ €220,000 estimated

The accounts state no turnover.

Liquidity

71.21 was 39.42 in 2024

Short-term debts fell from €34,508 to €21,409.

Filings

15 annual accounts since 2011
AprilJune31 JulyOctober201520202025

Seven of the last ten came late. The 2019 accounts came latest: 61 days after the end of the period.

Position in the sector

99.4%

Higher solvency than 95% of companies in human health. Sector median 59.2% · 3,053 companies.

Checked score

92
Excellent
Financially stronger than 39% of small companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 1,080 companies (NACE 86, small).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

100=equity 99.4% of total assets
53-6short-term debt 0.6% · cash 2.8%
49+4return on assets 4.8%

Score breakdown

raises risk
Liquidity: current ratio 71.21, cash €103,052, halved
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €3.7m
Figures for financial year 2025 (filed on 30-06-2026)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 77% of them on solvency, 30% on liquidity, 10% on profitability and 39% on growth.

The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit verdict

Credit of up to €340,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 71.21 (39.42 in 2024), above the usual 1.5. Short-term debt is 0.6% and cash 2.8% of total assets. 0.6% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €3.7m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 30-06-2026)
NBB · annual accounts
raises risk · Liquidity: current ratio 71.21, cash €103,052, halved
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2024
20 days late
2023
30 days late
2022
21 days early
2021
16 days late
2020
61 days late
2019
61 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 19 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 August (4 of the last 5 accounts filed within 37 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0836220271
New sole director SAPIN Céline Marie Anne appointed, SAPIN Jean-Michel resigned · Permanent representative: SAPIN Céline Marie Anne · Director discharge: SAPIN Jean-Michel · General meeting of 26-01-2023 · Gazette deed
New sole director SAPIN Céline appointed, SAPIN Jean-Michel resigned · Permanent representative: SAPIN Céline · “La pratique de l art dentaire dans toutes ses applications, soins, prothèses, orthodontie, l implantologie…” (deed in French) · General meeting of 26-01-2023 · Gazette deed
First establishment Rue Mitoyenne 14, Frameries
All 27 events

Comparable companies

same main activity, similar in size and age
Company
CELIDENT Frameries €3.7m €92,663 99.4% -
LOUIS-DELANGRE Nivelles €2.0m €86,606 2.1% -
HENCKENS Ravels €2.3m €71,078 70.9% -
LORE RYDE Bruges €1.8m €62,362 1.5% -
Bourlie Tervuren €1.8m €119,556 11.3% 1
CARDYN V Herentals €2.2m €151,952 96.2% 0.5
TITANIUM DENTAL Charleroi €2.2m €168,000 47.8% 1.6

These companies have the same main activity as CELIDENT: dental practice (NACE 86230). They are comparable in size and age: total assets between €1.8m and €2.3m, founded between 1999 and 2016.

Official details

Source: KBO
Status
Active since 28-04-2011Normal situation
Activity
Dental practiceNACE 86230
Establishment unit
2.199.464.7067080 Frameries, since 08-06-2011
Financial year end
31 December
Peppol
Reachable since 23-12-2025
Company details

Annual accounts 2025

€92,663▼ 0.9%
€177,185▲ 69.2%
€3.7m▲ 5.0%
€3.7m▲ 4.6%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on CELIDENT

CELIDENT files the abbreviated format. That format states no turnover. The gross margin rose from €50,497 in 2011 to €92,663 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

abbreviated format, filed on 30-06-2026, 31 days before the deadline
€92,663
▼ 0.9%
€91,643
▼ 1.0%
€177,185
▲ 69.2%
€1.5m
▲ 13.4%
99.4%
▲ 0.4 percentage points
71.21
▲ 31.79

The turnover shown is an estimate from the gross margin.

Turnover ≈ €220,000. Estimated: probably between €170,000 and €340,000.

In the rankings #2 company by equity in Frameries, Health and social work sector#4 company by total assets in Frameries, Health and social work sector#10 oldest company in Frameries, Health and social work sector

Balance sheet

balance sheet total €3.7m on 31-12-2025
What the company ownsHow it is paid for

in €m

in euro

Position in the sector

Compare with sector

99.4%

Higher than 95% of 3,053 companies in 2025.

71.21

Higher than 95% of 2,997 companies in 2025.

4.8%

Higher than 23% of 3,009 companies in 2025.

CELIDENT Middle half of the sector 80% of the sector Abbreviated accounts in human health (NACE 86)

Net result: middle half · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023202220212020201920182017201620152014201320122011
Balance sheet: assets
20/58 3.7m3.6m3.5m3.2m3.2m2.8m2.8m2.7m2.6m2.7m2.6m2.4m2.4m2.4m58,003
21/28 2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m6,000
22/27 -------1222433654,5178,15012,26916,1206,000
23 -------122243365487----
24 ----------4,0308,15012,26916,1206,000
28 2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m-
29/58 1.5m1.4m1.3m1.0m956,013628,157565,320491,263410,954478,774415,914178,855165,589220,30052,003
40/41 426,494316,929318,585173,65294,987117,506342,846333,569332,663323,087319,701104,845104,022118,9276,653
40 ---------4,030--18011,857-
41 426,494316,929318,585173,65294,987117,506342,846333,569332,663319,057319,701104,845103,842107,0706,653
50/53 994,569788,569859,277623,759688,658----------
54/58 103,052254,84679,706251,859172,368510,651222,454157,69378,291154,40493,10667,88551,21285,54543,453
490/1 318-----19--1,2833,1066,12510,35415,8281,897
Balance sheet: equity and liabilities
10/49 3.7m3.6m3.5m3.2m3.2m2.8m2.8m2.7m2.6m2.7m2.6m2.4m2.4m2.4m58,003
10/15 3.7m3.5m3.4m3.2m3.1m2.8m2.8m2.7m2.6m2.5m2.5m2.1m1.9m1.9m42,048
10/11 12,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,400
100 ------18,60018,60018,60018,60018,60018,60018,60018,60018,600
101 ------6,2006,2006,2006,2006,2006,2006,2006,2006,200
13 3.7m3.5m3.4m3.2m3.1m2.8m2.7m2.7m2.6m2.5m2.5m2.1m1.9m1.9m29,648
130/1 ---1,8601,8601,860---------
130 ------1,8601,8601,8601,8601,8601,8601,8601,8601,860
1311 ---1,8601,8601,860---------
133 3.7m3.5m3.4m3.2m3.1m2.8m2.7m2.7m2.6m2.5m2.5m2.1m1.9m1.8m27,788
17/49 21,41134,50824,44456,77651,3491,84013,09511,436644144,086155,084318,486453,446572,37515,955
17 ----------60,644242,477305,500369,711-
170/4 ----------60,644122,477185,500249,711-
178/9 -----------120,000120,000120,000-
42/48 21,40934,50824,44456,77651,3491,84013,09511,436644144,08694,44076,009142,546202,66415,955
42 ---------120,64461,83363,02264,21265,401-
44 2,1132,4032,1002,3722,911----275269433282387-
440/4 2,1132,4032,1002,3722,911----275269433282387-
45 17,41820,10520,58052,64146,674396--19310,06520,5192,941-58,82415,955
450/3 17,41820,10520,58052,64146,674396--19310,06520,5192,941-58,82415,955
47/48 1,87712,0001,7641,7641,7641,44413,09511,43645113,10211,8199,61278,05278,052-
492/3 2-----------5,401--
Income statement
9900 92,66393,54993,37593,34591,47492,12690,35487,266113,226106,070103,200107,930101,51484,01650,497
630 ------1221221221224,2414,1204,1204,0305,160
640/8 1,0199891,137868868----------
9901 91,64392,56192,23892,47790,60692,12690,23387,144113,104105,94898,959103,81197,39579,98645,337
75/76B 124,99015,741158,38989,968236,466-49322704567340,69380,8938641.8m280
75 124,99015,741158,38989,968236,466-49322704567340,69380,8938641.8m280
65/66B 106-29,064-35,45765,1611571391291297581,9283,1174,3065,4959012
65 106-29,064-35,45765,1611571391291297581,9283,1174,3065,4959012
9903 216,527137,366286,084117,284326,91591,98790,59787,037113,050104,587436,534180,39892,7631.9m45,604
67/77 39,34232,65245,45429,45348,56817,89618,32017,64337,55034,88139,70636,29232,39658,87615,956
9904 177,185104,714240,63087,830278,34774,09172,27769,39575,50169,706396,828144,10660,3671.8m29,648
9905 177,185104,714240,63087,830278,34774,09172,27769,39575,50169,706396,828144,10660,3671.8m29,648
Appropriation of the result
9906 177,185104,714240,63087,830278,34774,09172,27769,39575,50169,706396,828144,10660,3671.8m29,648
791/2 -12,000-------------
691/2 177,185104,714240,63087,830278,34774,09172,27769,39575,50169,706396,828144,10660,3671.8m29,648
6920 --------------1,860
6921 177,185104,714240,63087,830278,34774,09172,27769,39575,50169,706396,828144,10660,3671.8m27,788
694/7 -12,000-------------
694 -12,000-------------
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 30-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 abbreviated format 30-06-2026 2026-00224583 PDF
31-12-2024 full format 20-08-2025 2025-00386455 PDF
31-12-2023 full format 30-08-2024 2024-00431126 PDF
31-12-2022 full format 10-07-2023 2023-00226534 PDF
31-12-2021 full format 16-08-2022 2022-20293187 PDF
31-12-2020 full format 30-09-2021 2021-69900499 PDF
31-12-2019 full format 30-09-2020 2020-57200097 PDF
31-12-2018 full format 30-08-2019 2019-60400497 PDF
31-12-2017 full format 29-06-2018 2018-26900459 PDF
31-12-2016 full format 31-08-2017 2017-56400247 PDF
31-12-2015 full format 08-08-2016 2016-40900503 PDF
31-12-2014 full format 24-08-2015 2015-47700352 PDF
31-12-2013 full format 28-08-2014 2014-51700297 PDF
31-12-2012 full format 30-08-2013 2013-57000195 PDF
31-12-2011 full format 28-08-2012 2012-47200587 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023202220212020201920182017201620152014201320122011
------90,35487,266113,226106,070103,200107,930101,51484,01650,497
------72,39869,51675,62269,828401,070148,22664,4871.8m34,808
------000-4,03060902692.2m9,000
-151,795175,140-172,15379,492-338,283288,19764,76179,402-76,11361,29825,22116,673-34,33342,091-
1.5m1.3m1.2m992,494904,663626,316552,225479,827410,310334,688321,474102,84623,04317,63636,048
99.4%99.0%99.3%98.3%98.4%99.9%99.5%99.6%100.0%94.6%94.1%86.7%80.9%76.5%72.5%
71.2139.4251.4518.4818.62-43.1742.96-3.324.402.351.161.093.26
0.010.010.010.020.020.000.000.000.000.060.060.150.240.310.38
4.8%3.0%7.0%2.8%9.0%2.6%2.6%2.6%2.9%2.7%16.1%7.0%3.1%97.7%70.5%
4.8%2.9%7.0%2.7%8.8%2.6%2.6%2.6%2.9%2.6%15.1%6.0%2.5%74.8%51.1%

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on CELIDENT

The operating result for 2025 is 1% lower than in 2024 and the lowest since 2021.

Debt's share of the balance-sheet total falls from 1.0% to 0.6%. Equity is higher and debt is lower.

Board & ownership

Board

1 director, last change in 2023
SAPIN Céline Marie Anne
Sole director
since 26-01-2023
listed in the 2025 annual accounts, filed on 30-06-2026

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
SAPIN Céline Marie Anne
Sole director
SAPIN Jean-Michel
Manager
BoardEarliermandate already running before its first mention
Mandates as a list
  • SAPIN Céline Marie Anne
    • Sole director, from 28-04-2011 to date
  • SAPIN Jean-Michel
    • Manager, from 28-04-2011 to 02-03-2023
    • Manager, until 10-03-2023

See the board, name and registered office on a given date →

Control

See the annual accounts at the National Bank and the publications in the Belgian Official Gazette.

Capital

Contribution
€12,400
Source
deed of 10-03-2023

Articles of association

deed of 02-03-2023 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited

Capital transactions

Capital over time
  1. 10-03-2023 Converted to available equity · €12,400
  2. 02-03-2023 Converted to available equity · €12,400

Network & group

Holdings

own 2025 accounts, the bar shows equity in euros
This companyCELIDENT1 holding, 1 country 2025 accounts

Belgium 1 Equity Result

Source: list of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.

The LEI register names no parent.

At the same address

Rue Mitoyenne 14, 7080 Frameries · 1 other company
CENTRE DENTAIRE ET DE RECHERCHE
registered office since 02-04-1987 · founded in 1987
 0.5 FTE (2025)
0430.830.844

Holdings and subsidiaries

1 holding

Holdings 1

Share, source and own figures per holding (1)
Holdings through the years 2012 to 2025
Holdings through the years
Name20122013201420152016201720182019202020212022202320242025
CENTRE DENTAIRE ET DE RECHERCHE 100%

Source: list of holdings in its own accounts

Connections & network

1 current director
Depth

The network starts from the directors of CELIDENT. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Timeline

27 events since 2011

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBabbreviated format · 31 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0836220271
Annual accounts 2024 filed PDFfull format · 20 days late
2024
Annual accounts 2023 filed PDFfull format · 30 days late
2023
Liquidity more than doubled current ratio 51.45 The current ratio rises from 18.48 to 51.45. Short-term debt falls from €56,776 to €24,444.
Annual accounts 2022 filed PDFfull format · 21 days before the deadline
New sole directorSAPIN Céline Marie Anne appointed, SAPIN Jean-Michel resigned · Permanent representative: SAPIN Céline Marie Anne · Director discharge: SAPIN Jean-Michel · General meeting of 26-01-20238 points ▸

Open the deed in the Belgian Official Gazette

New sole directorSAPIN Céline appointed, SAPIN Jean-Michel resigned · Permanent representative: SAPIN Céline · “La pratique de l art dentaire dans toutes ses applications, soins, prothèses, orthodontie, l implantologie…” (deed in French) · General meeting of 26-01-20238 points ▸
  • Director resignation, SAPIN Jean-Michel (manager)
  • Director discharge, SAPIN Jean-Michel
  • Director appointment, SAPIN Céline (sole director)
  • Permanent representative, SAPIN Céline
  • General meeting, 26-01-2023
  • Registered office clause, Rue Mitoyenne, n°14, 7080 Frameries (Eugies)
  • Purpose change, “La pratique de l art dentaire dans toutes ses applications, soins, prothèses, orthodontie, l implantologie, mécanique et radiographie dentaire, de même que la…” (deed in French)
  • 186 shares
  • The deed holds 7 more points.

Open the deed in the Belgian Official Gazette

2022
Annual accounts 2021 filed PDFfull format · 16 days late
2021
Annual accounts 2020 filed PDFfull format · 61 days late
2020
Liquidity more than 7 times current ratio 341.34 The current ratio rises from 43.17 to 341.34. Short-term debt falls from €13,095 to €1,840.
Annual accounts 2019 filed PDFfull format · 61 days late
2019
Annual accounts 2018 filed PDFfull format · 30 days late
2018
Annual accounts 2017 filed PDFfull format · 32 days before the deadline
2017
Liquidity times 192 current ratio 638.01 The current ratio rises from 3.32 to 638.01. Short-term debt falls from €144,086 to €644.
Annual accounts 2016 filed PDFfull format · 31 days late
2016
Annual accounts 2015 filed PDFfull format · 8 days late
2015
Annual accounts 2014 filed PDFfull format · 24 days late
2014
Liquidity doubles current ratio 2.35 The current ratio rises from 1.16 to 2.35. Short-term debt falls from €142,546 to €76,009.
Equity above €2m equity €2.1m ▲7.5% With a profit in every financial year since 2011, equity grows to €2.1m.
Annual accounts 2013 filed PDFfull format · 28 days late
2013
Annual accounts 2012 filed PDFfull format · 30 days late
2012
Highest result from 2011 to 2025 net €1.8m ▲6,045% The net result of €1.8m is the highest of those years.
Equity above €1m equity €1.9m ▲4,333% With a profit in every financial year since 2011, equity grows to €1.9m.
Annual accounts 2011 filed PDFfull format · 28 days late
2011
First establishment Rue Mitoyenne 14, Frameries
Incorporation PDFpublished on 24-05-2011

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

CELIDENT was incorporated on 28 April 2011.1 Total assets rose from €2.7m in 2018 to €3.7m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Company details

Identity

Enterprise number
0836.220.271
VAT number
BE 0836.220.271
Peppol ID
0208:0836220271
LEI code
984500BC91F8DCD83710 live in the LEI register
Legal form
Private limited company
Status
Active, normal situation
Founded
28-04-2011
Financial year
ends on 31 December
Peppol
Reachable since 23-12-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
CELIDENT in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 02-03-2023 (in French)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Région Wallonne”
deed of 10-03-2023 (in French)

Activities

NACEBEL 2025
86230 Dental practice main activity
Codes under NACEBEL 2008
86230 Human health activities main activity

Registered office and establishments

1 establishment
Establishment Since Unit number
Rue Mitoyenne 14 registered office 7080 Frameries 08-06-2011 2.199.464.706

Buildings and parcels at the address

Ground area
847 m²
Buildings
163 m²
Volume, LiDAR
805 m³
Tallest building
6.6 m
Buildings to scale, each on its own parcel
163 m², 6.6 m 163 m², 6.6 m

Location

registered office establishment The establishment unit on the map
2 companies at this address See who is registered here

Parcels

Cadastral parcelArea Buildings Height / floors
53025D0807/00H000847 m² 1 · 163 m² 6.6 m · 2

We would like to set cookies. That happens only with your consent. What we measure